Form 4 holding
10%+ Owner
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 30,253,189
- Estimated value
- $68,977,271
- Report date
- 21 Jun 2021
- Price
- $2.28
- Ownership
- Indirect
GSK plc - 10%+ Owner at Lyell Immunopharma, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- LYEL on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by GSK plc since 16 Aug 2025
Reported holdings for GSK plc in Lyell Immunopharma, Inc.
Form 4 holding
10%+ Owner
Lyell Immunopharma, Inc.
- Security class
- Series AA Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 21 Jun 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for GSK plc in Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.